Bone unfriendly drugs – which drugs can cause osteoporosis?

Written by: Professor Gordana Prelevic
Published: | Updated: 03/05/2019
Edited by: Jay Staniland

Some patients on certain types of medication are at a higher risk of developing osteoporosis, with the medication having negative effects on bone health. The risk is especially higher in recently menopausal women (within four years of menopause), those who previously had low bone density or have already experienced fragility fracture, those who have a family history of osteoporosis, smokers, patients who have excessive alcohol intake, and those who are vitamin D deficient. Leading consultant endocrinologist, Professor Gordana Prelevic explains which kinds of medication pose a risk to bone health.

 

Which medications are a risk to bone health?

 

The following drugs are known to decrease bone health while the patient is on a course of medication:

  • Corticosteroids are used for the treatment of asthma, arthritis, systemic lupus, multiple sclerosis and numerous other conditions
  • Phenobarbital and phenytoin are used to treat epilepsy
  • Aromatase inhibitors (anastrazol, letrozol) are used to treat breast cancer
  • GnRH agonists (goserelin, buserelin, triptorelin) are used for treatment of endometriosis, prostate cancer and in IVF
  • Proton pump inhibitors (omeprazole, lansoprazole, esomeprazole) are used for treatment of gastro-esophageal reflux, heartburn, peptic ulcer
  • Heparin is used for prevention of blood clots
  • Depo-Provera is used for long-term contraception
  • Serotonin re-uptake inhibitors (fluoxetine, escitalopram) are used for treatment of depression
  • Thyroxine used in patients with underactive thyroid if taken in excessive amount

 

How can you prevent bone loss?

 

If you are on one of medications listed above, there are a few ways you can reduce the degree of bone loss you experience:

  • the lowest possible dose should be used for the shortest possible time
  • ensure you have adequate calcium intake (1 - 1.5g daily)
  • optimising your vitamin D levels (usually achieved by taking 1000 - 2000IU of vitamin D daily)
  • weight-bearing and muscle-strengthening exercises should be encouraged whenever possible

Any patient on long term therapy with known bone unfriendly medications should ask their doctor for a DXA scan for assessment of bone density.


Bone loss is reversible in most cases, once the medication is stopped.


If you are prescribed one or more of the medications mentioned, and want to seek advice on reducing the risk to your bone health, make an appointment with a specialist.

By Professor Gordana Prelevic
Endocrinology, diabetes & metabolism

Professor Gordana Prelevic is one of London's leading consultant endocrinologists with over 40 years of experience. Her main area of expertise is reproductive endocrinology with special interests in polycystic ovary syndrome (PCOS), menopause, and osteoporosis

Professor Prelevic earned a Doctor of Medicine (MD) in 1971, a Master of Science (MSc) in endocrinology in 1978, and a Doctor of Science (DSc) in reproductive endocrinology in 1985, all from the University of Belgrade. She was a professor of medicine at the Belgrade University School of Medicine and head of the division of endocrinology at Zvezdara University Medical Centre, Belgrade until 1993, when she moved to the UK. In 1995 she was awarded a Fellowship of the Royal College of Physicians.  

Professor Gordana Prelevic practises at the Golders Green Outpatients & Diagnostic Centre and the Platinum Medical Centre. In her clinic, she sees patients with a wide range of hormonal disorders and a large proportion of her work focuses on the management of perimenopausal and postmenopausal women. Additionally, she sees patients with unwanted hair growth (hirsutism), hyperprolactinaemia, infertility, and thyroid disorders. 

She has published extensively, particularly on various aspects of PCOS in peer-reviewed journals and has contributed to numerous book chapters. Her work has been presented at several scientific meetings internationally. From 1996 to 2005, she held a position as a senior lecturer in reproductive endocrinology at Royal Free & University College London Medical School. She also works as an expert witness in endocrinology and forms an integral part of various reputable professional bodies. 

View Profile

Overall assessment of their patients


  • Related procedures
  • Alopecia
    Hyperhidrosis
    Eating disorders
    Erectile dysfunction
    Menopause
    Polycystic ovary syndrome (PCOS)
    Hypertension (high blood pressure)
    Infertility
    Disorder of sexual desire of man
    Clinical nutrition
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.